Literature DB >> 18375546

Renal anemia induced by chronic ingestion of depleted uranium in rats.

Hanaâ Berradi1, Jean-Marc Bertho, Nicolas Dudoignon, André Mazur, Line Grandcolas, Cédric Baudelin, Stéphane Grison, Philippe Voisin, Patrick Gourmelon, Isabelle Dublineau.   

Abstract

Kidney disease is a frequent consequence of heavy metal exposure and renal anemia occurs secondarily to the progression of kidney deterioration into chronic disease. In contrast, little is known about effects on kidney of chronic exposure to low levels of depleted uranium (DU). Study was performed with rats exposed to DU at 40 mg/l by chronic ingestion during 9 months. In the present work, a approximately 20% reduction in red blood cell (RBC) count was observed after DU exposure. Hence, three hypotheses were tested to determinate origin of RBC loss: (1) reduced erythropoiesis, (2) increased RBC degradation, and/or (3) kidney dysfunction. Erythropoiesis was not reduced after exposure to DU as revealed by erythroid progenitors, blood Flt3 ligand and erythropoietin (EPO) blood and kidney levels. Concerning messenger RNA (mRNA) and protein levels of spleen iron recycling markers from RBC degradation (DMT1 [divalent metal transporter 1], iron regulated protein 1, HO1, HO2 [heme oxygenase 1 and 2], cluster of differentiation 36), increase in HO2 and DMT1 mRNA level was induced after chronic exposure to DU. Kidneys of DU-contaminated rats had more frequently high grade tubulo-interstitial and glomerular lesions, accumulated iron more frequently and presented more apoptotic cells. In addition, chronic exposure to DU induced increased gene expression of ceruloplasmin (x12), of DMT1 (x2.5), and decreased mRNA levels of erythropoietin receptor (x0.2). Increased mRNA level of DMT1 was associated to decreased protein level (x0.25). To conclude, a chronic ingestion of DU leads mainly to kidney deterioration that is probably responsible for RBC count decrease in rats. Spleen erythropoiesis and molecules involved in erythrocyte degradation were also modified by chronic DU exposure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18375546     DOI: 10.1093/toxsci/kfn052

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  6 in total

1.  Human Health and the Biological Effects of Tritium in Drinking Water: Prudent Policy Through Science - Addressing the ODWAC New Recommendation.

Authors:  S Dingwall; C E Mills; N Phan; K Taylor; D R Boreham
Journal:  Dose Response       Date:  2011-02-22       Impact factor: 2.658

Review 2.  The toxicity of depleted uranium.

Authors:  Wayne Briner
Journal:  Int J Environ Res Public Health       Date:  2010-01-25       Impact factor: 3.390

3.  Deciphering the energy landscape of the interaction uranyl-DCP with antibodies using dynamic force spectroscopy.

Authors:  Jean-Marie Teulon; Pierre Parot; Michael Odorico; Jean-Luc Pellequer
Journal:  Biophys J       Date:  2008-09-12       Impact factor: 4.033

Review 4.  Health effects of naturally radioactive water ingestion: the need for enhanced studies.

Authors:  Irina Guseva Canu; Olivier Laurent; Nathalie Pires; Dominique Laurier; Isabelle Dublineau
Journal:  Environ Health Perspect       Date:  2011-08-02       Impact factor: 9.031

5.  Unexpected lack of deleterious effects of uranium on physiological systems following a chronic oral intake in adult rat.

Authors:  Isabelle Dublineau; Maâmar Souidi; Yann Gueguen; Philippe Lestaevel; Jean-Marc Bertho; Line Manens; Olivia Delissen; Stéphane Grison; Anaïs Paulard; Audrey Monin; Yseult Kern; Caroline Rouas; Jeanne Loyen; Patrick Gourmelon; Jocelyne Aigueperse
Journal:  Biomed Res Int       Date:  2014-02-12       Impact factor: 3.411

6.  Metabolomics identifies a biological response to chronic low-dose natural uranium contamination in urine samples.

Authors:  Stéphane Grison; Gaëlle Favé; Matthieu Maillot; Line Manens; Olivia Delissen; Eric Blanchardon; Nathalie Banzet; Catherine Defoort; Romain Bott; Isabelle Dublineau; Jocelyne Aigueperse; Patrick Gourmelon; Jean-Charles Martin; Maâmar Souidi
Journal:  Metabolomics       Date:  2013-05-21       Impact factor: 4.290

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.